GPT Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve 1. Audited Financial Results for the quarter and year ended March 31, 2025, 2. The recommendation of final dividend, if any, on the equity share capital of the company for the FY 2024-25.